摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3R-cis)-1,9-dihydro-9--6H-purin-6-one (Iso-ddI) | 143191-81-5

中文名称
——
中文别名
——
英文名称
(3R-cis)-1,9-dihydro-9--6H-purin-6-one (Iso-ddI)
英文别名
1,4-Anhydro-2,3-dideoxy-2-(1,6-dihydro-6-oxo-9H-purin-9-yl)-D-arabinitol;(3R-cis)-1,9-dihydro-9-[tetrahydro-5-(hydroxymethyl)-3-furanyl]-6H-purin-6-one (Iso-ddI);9-[(3S,5S)-5-(hydroxymethyl)oxolan-3-yl]-1H-purin-6-one
(3R-cis)-1,9-dihydro-9-<tetrahydro-5-(hydroxymethyl)-3-furanyl>-6H-purin-6-one (Iso-ddI)化学式
CAS
143191-81-5
化学式
C10H12N4O3
mdl
——
分子量
236.23
InChiKey
OENKSAWKKLMVEL-BQBZGAKWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.2
  • 重原子数:
    17
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    88.7
  • 氢给体数:
    2
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Synthesis and anti-HIV activity of isonucleosides
    作者:Donna M. Huryn、Barbara C. Sluboski、Steve Y. Tam、Manfred Weigele、Iain Sim、Barry D. Anderson、Hiroaki Mitsuya、Samuel Broder
    DOI:10.1021/jm00091a001
    日期:1992.6
    A series of isomeric 2',3'-dideoxynucleosides which contains a modified carbohydrate moiety has been prepared. This class of compounds was designed to mimic the activity of known anti-HIV dideoxynucleosides, while imparting enhanced chemical and enzymatic stability. Isonucleosides containing the standard heterocyclic bases (A, C, G, T) were synthesized via nucleophilic addition of the base to an isomeric sugar unit. Modified derivatives were generated by manipulation of the intact isonucleoside. Two of the compounds prepared, iso-ddA (1) and iso-ddG (6), exhibit significant and selective anti-HIV activity, as well as beneficial hydrolytic stability.
  • US5231174A
    申请人:——
    公开号:US5231174A
    公开(公告)日:1993-07-27
  • [EN] 2'ISODIDEOXY-(BETA)-D-NUCLEOSIDES AS STABLE ANTIVIRAL AGENTS
    申请人:UNIVERSITY OF IOWA RESEARCH FOUNDATION
    公开号:WO1993017035A1
    公开(公告)日:1993-09-02
    (EN) The present invention is concerned with new 2'-isomeric 2', 3'-dideoxy-2'$g(b)-D-nucleosides and their derivatives where the base moiety has $g(b)-stereo-chemistry but is transposed from the normal 1'-position to the 2'-position and the carbohydrate moiety has the D-configuration at the 4'-position. These compounds are resistant towards hydrolytic cleavage of the glycosidic bond and are resistant to enzymatic deamination. They have potential in the treatment or prophylaxis of viral infections, particularly retroviral infections and especialy AIDS.(FR) La présente invention concerne de nouveaux 3'-didésoxy-2'$g(b)-D nucléosides 2'-isomère 2' et leurs dérivés. La fraction de base possède une stéréochimie $g(b), mais est transposée de la position normale 1'- à la position 2'- et la fraction de glucide possède la configuration D à la position 4'-. Ces composés sont résistants au clivage hydrolytique de la liaison glycosidique et sont également résistants à la désamination enzymatique. Ils sont puissants dans le traitement ou la prophylaxie d'infections virales, notamment des infections rétrovirales et en particulier du SIDA.
  • Novel isomeric dideoxynucleosides as potential antiviral agents
    作者:Pascal J. Bolon、Todd B. Sells、Zoraida M. Nuesca、David F. Purdy、Vasu Nair
    DOI:10.1016/s0040-4020(01)85259-5
    日期:1994.1
    Novel isomeric dideoxynucleosides with S,S absolute stereochemistry and involving the transposition of the base moiety from the normal 1'- to the 2'-position have been regiospecifically and stereospecifically synthesized. The synthetic approaches involved either direct coupling with inversion at the 2-position of a preformed dideoxygenated sugar using the base moiety as nucleophile (for purine isodideoxynucleosides) or construction of the base moiety onto a stereochemically defined amino sugar precursor (pyrimidine isodideoxynucleosides). These compounds possess extremely high stability with respect to ''glycosidic'' bond cleavage and enzymatic deamination. Antiviral data suggest that the most active compound was levorotatory S,S-isodideoxyadenosine.
查看更多